Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis

[1]  T. Kooistra,et al.  Mouse models for atherosclerosis and pharmaceutical modifiers. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[2]  J. Bernhagen,et al.  MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment , 2007, Nature Medicine.

[3]  T. Hirata,et al.  Trans geometric isomers of EPA decrease LXRα-induced cellular triacylglycerol via suppression of SREBP-1c and PGC-1β Published, JLR Papers in Press, September 27, 2006. , 2006, Journal of Lipid Research.

[4]  H. Kolb,et al.  Inflammation in Metabolic Syndrome and Type 2 Diabetes , 2006, Annals of the New York Academy of Sciences.

[5]  H. Hendriks,et al.  High-protein and high-carbohydrate breakfasts differentially change the transcriptome of human blood cells. , 2006, The American journal of clinical nutrition.

[6]  W. Koenig,et al.  Fenofibrate Reduces Atherogenesis in ApoE*3Leiden Mice: Evidence for Multiple Antiatherogenic Effects Besides Lowering Plasma Cholesterol , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[7]  W. Lauchart,et al.  Expanded criteria liver donors (ECD): effect of cumulative risks. , 2006, Annals of transplantation.

[8]  T. Kooistra,et al.  Transgenic flavonoid tomato intake reduces C-reactive protein in human C-reactive protein transgenic mice more than wild-type tomato. , 2006, The Journal of nutrition.

[9]  B. Coll,et al.  Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. , 2006, Biochemical and biophysical research communications.

[10]  T. Kooistra,et al.  HMG-CoA reductase inhibitors: effects on chronic subacute inflammation and onset of atherosclerosis induced by dietary cholesterol. , 2005, Current drug targets. Cardiovascular & haematological disorders.

[11]  D. Steinberg.  Hypercholesterolemia and inflammation in atherogenesis: two sides of the same coin. , 2005, Molecular nutrition & food research.

[12]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. Drexler,et al.  Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis. , 2005, Atherosclerosis.

[14]  J. H. van Bockel,et al.  Up-regulation and coexpression of MIF and matrix metalloproteinases in human abdominal aortic aneurysms. , 2005, Antioxidants & redox signaling.

[15]  A. Chait,et al.  Cholesterol Feeding Increases C-Reactive Protein and Serum Amyloid A Levels in Lean Insulin-Sensitive Subjects , 2005, Circulation.

[16]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[17]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[18]  Robert Kleemann,et al.  Effect of Low Dose Atorvastatin Versus Diet-Induced Cholesterol Lowering on Atherosclerotic Lesion Progression and Inflammation in Apolipoprotein E*3–Leiden Transgenic Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Allan R Brasier,et al.  Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway. , 2004, Physiological genomics.

[20]  Matej Oresic,et al.  Integrative biological analysis of the APOE*3-leiden transgenic mouse. , 2004, Omics : a journal of integrative biology.

[21]  Paul M. Ridker,et al.  Inflammation as a Cardiovascular Risk Factor , 2004, Circulation.

[22]  K. Reue,et al.  Cholesterol and Cholate Components of an Atherogenic Diet Induce Distinct Stages of Hepatic Inflammatory Gene Expression* , 2003, Journal of Biological Chemistry.

[23]  Robert Kleemann,et al.  Rosuvastatin Reduces Atherosclerosis Development Beyond and Independent of Its Plasma Cholesterol–Lowering Effect in APOE*3-Leiden Transgenic Mice: Evidence for Antiinflammatory Effects of Rosuvastatin , 2003, Circulation.

[24]  M. Willingham,et al.  Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol. , 2003, The American journal of pathology.

[25]  F. Mach,et al.  Reduced Connexin43 Expression Inhibits Atherosclerotic Lesion Formation in Low-Density Lipoprotein Receptor–Deficient Mice , 2003, Circulation.

[26]  Daniel Steinberg,et al.  Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime , 2002, Nature Medicine.

[27]  I. Jolliffe.  Principal Component Analysis , 2002, International Encyclopedia of Statistical Science.

[28]  R. Bucala,et al.  Regulation of the CTL Response by Macrophage Migration Inhibitory Factor , 2001, The Journal of Immunology.

[29]  H. Shimano,et al.  Sterol regulatory element-binding protein-1 as a dominant transcription factor for gene regulation of lipogenic enzymes in the liver. , 2000, Trends in cardiovascular medicine.

[30]  P. Doevendans,et al.  Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage. , 1999, Circulation.

[31]  E. Braunwald.  Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[32]  R. Gebhard,et al.  Oral acetylsalicylic acid induces biliary cholesterol secretion in the rat , 1997, Lipids.

[33]  L. Havekes,et al.  Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[34]  R. Frants,et al.  Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. , 1994, The Journal of clinical investigation.

[35]  C. Blum,et al.  Role of dietary intervention in the primary prevention of coronary heart disease. Individuals with high-normal or elevated serum cholesterol levels should be placed on cholesterol-lowering diets. , 1987, Cardiology.

[36]  T. Hirata,et al.  Trans geometric isomers of EPA decrease LXRalpha-induced cellular triacylglycerol via suppression of SREBP-1c and PGC-1beta. , 2006, Journal of lipid research.

[37]  J. Bernhagen,et al.  Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). , 2006, Atherosclerosis.

[38]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.

[39]  J. Joven,et al.  Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis , 2005, Molecular and Cellular Biochemistry.

[40]  E. Verheij,et al.  The role of mass spectrometry in systems biology : data processing and identification strategies in metabolomics , 2004 .

[41]  S. Shoelson,et al.  Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. , 2003, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[42]  F. Mach,et al.  Reduced Connexin 43 Expression Inhibits Atherosclerotic Lesion Formation in Low-Density Lipoprotein Receptor – Deficient Mice , 2003 .

[43]  A. Beynen,et al.  Inhibition of hepatic lipogenesis by salicylate. , 1982, Toxicology.

[44]  D. Jaiswal,et al.  Effect of salicylate and adrenocorticotropin on the hepatic and serum cholesterol in catfish, Heteropneustes fossilis (Bloch). , 1976, Acta biologica et medica Germanica.

[45]  Belsare Dk,et al.  Effect of salicylate and adrenocorticotropin on the hepatic and serum cholesterol in catfish, Heteropneustes fossilis (Bloch). , 1976 .